Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

NCT03059693 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: HAT1 topical cream
DRUG: Vehicle cream

Sponsor

Haus Bioceuticals